Third-party lab testing: 2 independent Janoshik assays on file, covering 2 substances.
Peptide supplier identified through Janoshik analytical testing records.
| NouvePen is listed as active. Discovered via Janoshik third-party lab testing.
| Substance | Measured purity | Test date |
|---|---|---|
| Retatrutide 40mg | not reported | undated |
| Rhgh 40 IU | not reported | undated |
None of these 2 assays carry a purity number on the certificate. They confirm the substance was submitted and tested, which is not the same as a measured result and not the same as a failure.
| Status | Active |
|---|---|
| Independent assays on file | 2 |
| Certificates of analysis | Vendor states COAs are available |
| Vendor type | Research-use supplier |
| NouvePen is listed as active and we hold 2 independent Janoshik assays on file. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 2 third-party Janoshik assays for | NouvePen, covering 2 substances.
Tested substances: Retatrutide 40mg.
Similar vendors: Hangzhou Mandy Biotechnology, Apex Peptides, Licensed Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: NOVA Labs UAE Peptides Review, Nova Vitality Peptides Review, NovaPeptide Review.